Repaglinide Tablet
Product Images NDC 65862-672

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Repaglinide (NDC 65862-672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Repaglinide In Combination With Pioglitazone: Hba1c Values (Repaglinide Fig1)

A line graph depicting the percentage change in HbA1c over 24 treatment weeks for three groups: Repaglinide + Pioglitazone, Repaglinide alone, and Pioglitazone alone. The x-axis represents treatment weeks, while the y-axis shows the percentage change in HbA1c. The combination therapy shows a more pronounced decrease compared to each monotherapy.*

FDA Label Image

Package Label-principal Display Panel (0.5 mg (100 Tablet Bottle))

Repaglinide Tablets USP 0.5 mg tablets packaging label from Aurobindo Pharma Limited, with 100 tablets per container. The label includes storage instructions, dosage reminder to see package insert, and distributor information for Aurobindo Pharma USA. It displays the NDC 65862-670-01 and has barcode and manufacturing details indicating it is made in India.*

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Tablet Bottle))

Label for Repaglinide Tablets USP 1 mg, a tablet dosage form drug distributed by Aurobindo Pharma USA, Inc. The label specifies storage instructions, dosage guidance, and packaging details for 100 tablets. It includes the NDC 65862-671-01 and indicates the product is made in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablet Bottle))

Repaglinide Tablets USP 2 mg label for 100 tablets by Aurobindo Pharma Limited. The label includes storage instructions, dosage reference, distributor details, and a barcode. It specifies repaglinide USP 2 mg per tablet and highlights the product is for prescription use only.*

FDA Label Image

Chemical Structure (Repaglinide Str)

Chemical structure diagram of Repaglinide, a molecule with chemical groups including a phenyl ring, carboxylic acid, and amide linkages, representing the active ingredient in the drug Repaglinide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.